Apr 25 |
Best Value Stocks to Buy for April 25th
|
Apr 25 |
Best Income Stocks to Buy for April 25th
|
Apr 23 |
Neurocrine succeeds in mid-stage trial for Takeda-partnered depression drug
|
Apr 23 |
Takeda Pharmaceutical: A Long-Term Cash Cow
|
Apr 23 |
Neurocrine Biosciences Reports Positive Phase 2 Data for NBI-1065845 in Adults with Major Depressive Disorder
|
Apr 22 |
Pharmas form joint venture to jumpstart Japanese drug research
|
Apr 22 |
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
|
Apr 19 |
MasterCraft Boat, SentinelOne, and More Stocks See Action From Activist Investors
|
Apr 18 |
U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
|
Apr 8 |
Takeda Announces New U.S. Corporate Social Responsibility Program Partners to Build Equity through STEM Education and Access to Nutritional Food
|